z-logo
open-access-imgOpen Access
AB063. Potential synergistic effect by combination of PED-4 and PED-5 inhibitors plus theophylline in lung cancer?
Author(s) -
Kalliopi Domvri,
Wolfgang HohenforstSchmidt,
Νικόλαος Ζώγας,
Savvas Petanidis,
Paul Zarogoulidis,
Κonstantinos Porpodis,
Efi Kioseoglou
Publication year - 2016
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2016.ab063
Subject(s) - theophylline , lung cancer , medicine , pharmacology , drug , cancer , treatment of lung cancer , phosphodiesterase , combination therapy , cancer research , oncology , biology , enzyme , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom